Keyphrases
Adverse Reactions
14%
Blood-brain Barrier Integrity
14%
Central Nervous System
57%
Chemotherapy
28%
Cyclodextrin
14%
Cyclodextrin Inclusion Complex
100%
Encephalopathy
14%
Human African Trypanosomiasis
100%
Hydroxypropyl-β-cyclodextrin (HP-β-CD)
14%
Infection Progression
14%
Lymphoid Organs
14%
Magnetic Resonance Imaging
14%
Melarsoprol
100%
Murine Model
14%
Neurological Diseases
14%
Normal Blood
14%
Oral Treatment
14%
Parasite Load
14%
People at Risk
14%
Peripheral Organs
14%
Propylene Glycol
14%
Protozoan Parasites
14%
Sleeping Sickness
14%
Sub-Saharan Africa
14%
Trivalent Arsenicals
14%
Trypanocidal Activity
14%
Trypanosoma Brucei Gambiense
14%
Trypanosoma Brucei rhodesiense
28%
β-cyclodextrin (β-CD)
14%
Medicine and Dentistry
2 Hydroxypropyl Beta Cyclodextrin
12%
Adverse Event
12%
African Trypanosomiasis
100%
Beta Cyclodextrin
12%
Blood Brain Barrier
12%
Brain Disease
12%
Central Nervous System
50%
Cyclodextrin
100%
Disease
12%
In Vitro
12%
Infection
37%
Lymph Duct
12%
Magnetic Resonance Imaging
12%
Melarsoprol
100%
Neurologic Disease
12%
Organoarsenic Derivative
12%
Parasite (Microbiology)
25%
Parasite Load
12%
Propylene Glycol
12%
Trypanosoma Brucei
25%
Pharmacology, Toxicology and Pharmaceutical Science
2 Hydroxypropyl Beta Cyclodextrin
12%
Adverse Event
12%
African Trypanosomiasis
100%
Arsenical
12%
Beta Cyclodextrin
12%
Blood-Brain Barrier
12%
Brain Disease
12%
Chemotherapy
25%
Cyclodextrin
100%
Disease
12%
Infection
37%
Melarsoprol
100%
Neurologic Disease
12%
Propylene Glycol
12%
Protozoon
12%
Trypanosoma Brucei Gambiense
12%
Trypanosoma Brucei Rhodesiense
12%